Previous Close | 73.01 |
Open | 73.25 |
Bid | 73.47 x 100 |
Ask | 73.57 x 1000 |
Day's Range | 73.25 - 73.78 |
52 Week Range | 71.37 - 87.87 |
Volume | |
Avg. Volume | 7,534,552 |
Market Cap | 91.57B |
Beta (5Y Monthly) | 0.20 |
PE Ratio (TTM) | 16.33 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 3.08 (4.22%) |
Ex-Dividend Date | Mar 14, 2024 |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for GILD
Xilio will get just over $40 million from Gilead in return for a license to its experimental IL-12 immunotherapy. The biotech is also discontinuing other work and laying off staff.
In this article, we will be taking a look at the 20 biggest health care companies in Australia, 2024. If you do not want to learn about the global healthcare market, head straight to the 5 Biggest Health Care Companies in Australia, 2024. In 2024, Australia’s healthcare landscape will be dominated by a myriad of […]
Gilead Sciences (GILD) closed the most recent trading day at $72.58, moving -0.04% from the previous trading session.